Skip to main content

Advertisement

Log in

Evolution on experimental animal model for upper urothelium carcinogenesis

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

No optimal, well designed and reproducible animal model for upper urothelial carcinogenesis exists. This study characterized the histopathological features on top of immunolocalization of alpha-dystroglycans (α-DG) and matrix metalloproteinase (MMP-9) and cell turn-over in the upper urinary tract using a novel experimental model.

Methods

Seventy-five female Fischer 344 rats were divided into three groups: the control group received a 0.30-ml dose of 0.9% physiological saline; the MNU group (chemical carcinogen N-methyl-N-nitrosourea) received 0.30 ml of MNU; and the MNU-citrate group received 0.30 ml of MNU plus sodium citrate, every one intravesically every other week for a total of 4 doses. After 15 weeks, bladder, ureters and renal pelvis were collected for morphological and molecular analysis.

Results

Associated management with MNU and sodium citrate was able to lead to 100% of both urinary bladder and upper urinary tract tumors, being the high-grade noninvasive papillary urothelial carcinoma the most frequent lesion. The upper urothelium showed reduced α-DG and increased MMP-9 and Ki-67 immunoreactivities in the MNU-citrate group in relation to the other groups. MNU group presented no upper urothelium tumor and 100% bladder tumor.

Conclusions

This is a relevant evolution on experimental animal model for upper urinary tract carcinogenesis field. MMP-dependent disruption of the DG complex plays an important role in urothelial tumor carcinogenesis and showed the model applicability and significance. MNU-citrate model could contribute to a better understanding of human upper urothelial cancer development as well as to its local treatment strategies in a near future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Crallan RA, Georgopoulos NT, Sothgate J (2006) Experimental models of human bladder carcinogenesis. Carcinogenesis 27:374–381

    Article  CAS  PubMed  Google Scholar 

  2. Hicks RM, Wakefield JS (1972) Rapid induction of bladder cancer in rats with N-methyl-N-nitrosourea. Histology Chem Biol Interact 5:139–152

    Article  CAS  Google Scholar 

  3. Steinberg GD, Brendler CB, Squire RA (1991) Experimental intravesical therapy for superficial transitional cell carcinoma in a rat bladder tumor model. J Urol 145:647–653

    CAS  PubMed  Google Scholar 

  4. Kunze E, Graewe T, Scherber S (1989) Cell cycle dependence of N-methyl-N-nitrosourea-induced tumour development in the proliferating, partially resected rat urinary bladder. Br J Exp Pathol 70:125–142

    CAS  PubMed  Google Scholar 

  5. Reis LO, Pereira TC, Fávaro WJ, Cagnon VHA, Lopes-Cendes I, Ferreira U (2009) Experimental animal model and RNA interference: a promising association for bladder cancer research. World J Urol 27:353–361

    Article  CAS  PubMed  Google Scholar 

  6. Gupta R, Paner GP, Amin MB (2008) Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting. Adv Anat Pathol 15:127–139

    Article  PubMed  Google Scholar 

  7. Gen H, Yamamoto S, Morimura K, Min W, Mitsuhashi M, Murai T, Mori S, Hosono M, Oohara T, Makino S, Wanibuchi H, Fukushima S (2001) p53 and H-ras mutations and microsatellite instability in renal pelvic carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine: different genetic alteration from urinary bladder carcinoma. Jpn J Cancer Res 92:1278–1283

    CAS  PubMed  Google Scholar 

  8. Petersen OW, Ronnov JL, Howlett AR, Bissell MJ (1992) Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci USA 89:9064–9068

    Article  CAS  PubMed  Google Scholar 

  9. Brennan P, Jing J, Ethunandan M, Gorecki D (2004) Dystroglycan complex in cancer. Eur J Surg Oncol 30:589–592

    Article  CAS  PubMed  Google Scholar 

  10. Kamijima S, Tobe T, Suyama T, Ueda T, Igarashi T, Ichikawa T, Ito H (2005) The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter. Int J Urol 12:941–947

    Article  CAS  PubMed  Google Scholar 

  11. Epstein JI, Amin MB, Reuter VR, Mostofi FK (1998) Bladder Consensus Conference Committee. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 22:1435–1448

    Article  CAS  PubMed  Google Scholar 

  12. Fukushima S, Thamavit W, Kurata Y, Ito N (1986) Sodium citrate: a promoter of bladder carcinogenesis. Jpn J Cancer Res 77:1–4

    CAS  PubMed  Google Scholar 

  13. Ono S, Kurata Y, Shichino Y, Sano M, Fukushima S (1992) Synergism of environmental carcinogens and promoters on bladder cancer development initiated by N-butyl-N-(4-hydroxybutyl) nitrosamine in F344 rats. Jpn J Cancer Res 83:955–963

    CAS  PubMed  Google Scholar 

  14. Nunziata A, Storino AA (1982) Spontaneous neoplastic pathology in control rats—a review. Vet Hum Toxicol 24:243–247

    CAS  PubMed  Google Scholar 

  15. Sohn BH, Moon HB, Kim TY, Kang HS, Bae YS, Lee KK, Kim SJ (2001) Interleukin-10 up-regulates tumour-necrosis-factor-alpha-related apoptosis-inducing ligand (TRAIL) gene expression in mammary epithelial cells at the involution stage. Biochem J 360:31–38

    Article  CAS  PubMed  Google Scholar 

  16. Sgambato A, Migaldi M, Montanari M, Camerini A, Brancaccio A, Rossi G, Cangiano R, Losasso C, Capelli G, Trentini GP, Cittadini A (2003) Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am J Pathol 162:849–860

    CAS  PubMed  Google Scholar 

  17. Cross SS, Lippitt J, Mitchell A, Hollingsbury F, Balasubramanian SP, Reed MW, Eaton C, Catto JW, Hamdy F, Winder SJ (2008) Expression of beta-dystroglycan is reduced or absent in many human carcinomas. Histopathology 53:561–566

    Article  CAS  PubMed  Google Scholar 

  18. Kabashima A, Maehara Y, Kakehi Y (2000) Clinicopathological features and over-expression of matrix metalloproteinases in intramural gastric carcinoma with lymph node metastasis. Clin Cancer Res 6:3581–3584

    CAS  PubMed  Google Scholar 

  19. Yasumitu H, Miyazaki K, Umenishi F (1992) Comparison of extracellular matrix-degrading activities between 64-kDa and 90-kDa gelatinases purified in inhibitor-free forms from human schwannoma cells. J Biochem 111:74–80

    Google Scholar 

  20. Inoue K, Kamada M, Slaton JW (2002) The prognostic value of angiogenesis and metastasis related genes for progression of transitional cell carcinoma of renal pelvis and ureter. Clin Cancer Res 8:1863–1870

    CAS  PubMed  Google Scholar 

  21. Moses MA, Wiederschain D, Loughlin KR, Zurakowski D, Lamb CC, Freeman MR (1998) Increased incidence of matrix metalloproteinases in urine of cancer patients. Cancer Res 58:1395–1399

    CAS  PubMed  Google Scholar 

  22. Angell SK, Pruthi RS, Shortliffe LD (1998) The urodynamic relationship of renal pelvic and bladder pressures, and urinary flow rate in rats with congenital vesicoureteral reflux. J Urol 160:150–156

    Article  CAS  PubMed  Google Scholar 

  23. Burns CP, Rogengurt E (1984) Extracellular Na+ and initiation of DNA synthesis: role of intracellular pH and K+. J Cell Biol 98:1082–1089

    Article  CAS  PubMed  Google Scholar 

  24. Fukushima S, Tamano S, Shibata M, Kurata Y, Hirose M, Ito N (1988) The role of urinary pH and sodium ion concentration in the promotion stage of two-stage carcinogenesis of the rat urinary bladder. Carcinogenesis 9:1203–1206

    Article  CAS  PubMed  Google Scholar 

  25. Fukushima S, Shibata M, Shirai T, Tamano S, Ito N (1986) Roles of urinary sodium ion concentration and pH in promotion by ascorbic acid of urinary ladder carcinogenesis in rats. Cancer Res 46:1623–1626

    CAS  PubMed  Google Scholar 

  26. Oliveira PA, Colaco A, De la Cruz PLF (2006) Experimental bladder carcinogenesis-rodent models. Exp Oncol 28:2–11

    CAS  PubMed  Google Scholar 

  27. Vercesi LA, Constatantinon CE (1986) Pressure evaluation of the antireflux ability of the rat ureterovesical junction. Urol Int 41:192–195

    Article  CAS  PubMed  Google Scholar 

  28. Lipsky H (1971) Bladder inflammation and vesico-ureteral reflux. Experimental animal studies. Urol Int 26:217–240

    Article  CAS  PubMed  Google Scholar 

  29. Weiss RM (1987) Effect of pathologic processes and pharmacologic interventions on ureteral function. Semin Urol 5:167–175

    CAS  PubMed  Google Scholar 

  30. Anderstom C, Johansson SL, von Schultz L (1983) The influence of phenacetin or mechanical perforation on the development of renal pelvic and urinary bladder tumors in FANFT-induced urinary tract carcinogenesis. Acta Pathol Microbiol Immunol Scand Sect A 91:373–380

    Google Scholar 

Download references

Conflict of interest statement

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leonardo O. Reis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reis, L.O., Fávaro, W.J., Ferreira, U. et al. Evolution on experimental animal model for upper urothelium carcinogenesis. World J Urol 28, 499–505 (2010). https://doi.org/10.1007/s00345-010-0545-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-010-0545-3

Keywords

Navigation